Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

Mike PhilbrickHOLDRs PharmaceuticalPPHSTRONG BUYDec 30, 2025

Is the OG in this sector. Big volumes at a low MER of 0.36%. Holds large pharma names. Is a defensive healthcare play, which is needed for 2026's expected volatility. AI will be employed seriously in drug production--watch for this.

N/A

Stock price when the opinion was issued

biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

COMMENT

If you like the biotechnology/pharmaceutical sector, this is a good ETF. One of the ways investors tend to do that kind of a trade is to buy a small portion of the portfolio in the ETF itself and sprinkler around it 2 or 3 stocks that they think will do quite well.

PAST TOP PICK
(Past top pick December 5, up 11%) Will continue to play out.
PAST TOP PICK
(A top pick Sept 3/03. Up 2%.) Feels that 2004 will be a better time for pharmaceuticals. The stock is a good way for investors to lower their risk and play a decent value situation.
TOP PICK
A diversified way he can play the pharmaceutical sector. Good exposure for retail investors. This is a 1 to 3 year play.